Wegovy Lowers BMI in Young Children With Obesity, Clinical Trial Finds
Results from the STEP Young trial indicate that weekly semaglutide injections significantly reduced body mass index in children aged 6 to 11 with obesity compared to a placebo.
❤️Conditions & CarePhoto: medpagetoday.com
Key points
- Phase III STEP Young trial evaluated semaglutide in children ages 6 to 11 with obesity.
- Mean BMI decreased by 13.5% at week 68 in the treatment group compared to a 2.7% increase for placebo.
- Trial noted slower height velocity in the medication group, though bone age and density were similar.
A phase III clinical trial presented at the ObesityWeek annual meeting and published in the New England Journal of Medicine suggests that the GLP-1 medication semaglutide, marketed as Wegovy, can significantly reduce body mass index in children between the ages of 6 and 11 who have obesity. Led by researchers including Ania Jastreboff of the Yale School of Medicine, the STEP Young trial evaluated 167 children across 48 sites in nine countries over a 104-week period.
At week 68, the group receiving weekly semaglutide experienced a mean BMI decrease of 13.5%, whereas the placebo group saw a 2.7% increase. By the end of the 104-week treatment window, the BMI change remained markedly different, showing a 9.4% reduction for the medication group compared to an 8.4% increase for those taking the placebo. Additionally, nearly a third of the participants in the treatment arm dropped below the obesity threshold by week 104, versus just 2% of the placebo cohort.
While standard obesity management for young children usually relies on lifestyle changes, investigators noted that such interventions often yield modest and temporary results. However, utilizing powerful weight-loss medications in prepubertal patients requires careful monitoring, particularly concerning growth and development. The study recorded slower height velocity and reduced linear growth in the treatment group, though measures of bone age and mineral density were comparable between groups. Researchers emphasized that children with severe obesity face serious long-term health risks and significantly impacted quality of life.
What to know: The double-blind trial involved 167 participants who received either subcutaneous semaglutide or a placebo alongside lifestyle counseling. Readers should consult a qualified healthcare provider before making any personal medical or treatment decisions regarding weight management for children.
Source medpagetoday.com — medpagetoday.com/meetingcoverage/obesityweek/123910 ↗
Read next
🏃FitnessUnderstanding and Addressing Love Handles Through Lifestyle Changes
Experts clarify that spot reduction of fat is not physiologically possible, recommending a combination of calorie management and high-intensity interval training instead.
🏃FitnessCiele Releases New Woolmark-Certified Merino Winter Running Apparel
Montreal-based brand Ciele has launched its second collection of merino wool running gear, featuring performance-focused fabrics designed for cold-weather training.
🏥Public HealthPreventive Services Task Force Resumes Meetings Under New Leadership
The U.S. Preventive Services Task Force is set to reconvene this week for the first time in over a year following a significant membership overhaul by Health Secretary Ro…
🧠AI AnalysisUltraprocessed Diets May Impact Brain Reward Systems in Younger Adults
A Virginia Tech study suggests that individuals aged 18 to 21 may experience changes in brain reward processing after consuming ultraprocessed foods, a response not obser…
🧠Mind & Mental HealthAddressing Body Image and the Reality of Gluteal Anatomy
A personal reflection on the social and psychological impact of body shape, specifically regarding the gluteal region, and the limitations of consumer solutions for perce…
🔬ResearchCBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities
A double-blind clinical trial published in JAMA Pediatrics indicates that CBD oil provides no significant behavioral improvement for children and teenagers with intellect…